Convidado
MICHAEL E. WECHSLER
Investigador Principal do estudo MIRRA/mepolizumab em EGPA
Formado pela McGill University, Mestrado em Bioquímica e
Mestrado em Ciências Médicas pela Harvard University
Diretor, The Cohen Family Asthma Institute
Professor, Department of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health
Editor Associado, Allergy
Atividades
23/08/2019
09:10 às 09:40 - Role of Eosinophilic Inflammation in Chronic Respiratory Disease and possible therapeutic approaches
Speaker
23/08/2019
11:10 às 11:40 - Anti-IL5 Therapy for EGPA
Speaker
23/08/2019
12:10 às 12:40 - Management of Asthma in 2019 and Beyond
Speaker
23/08/2019
12:40 às 13:00 - Discussion and closing remarks
Participants